| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 38 | 41 | 35 | 45 | 42 | 38 | 39 | 36 | 45 | 71 | 76 | 74 | 80 | 83 | 85 | 87 | 68 | 68 | 73 | 76 | 74 | 83 | 92 | 103 | 97 | 99 | 89 | 94 | 111 |
| Expenses | 30 | 32 | 27 | 33 | 32 | 33 | 34 | 33 | 29 | 48 | 50 | 51 | 52 | 61 | 69 | 74 | 63 | 59 | 62 | 61 | 61 | 66 | 74 | 84 | 81 | 82 | 84 | 89 | 93 |
| EBITDA | 8 | 9 | 8 | 12 | 10 | 5 | 4 | 3 | 16 | 23 | 26 | 23 | 28 | 22 | 16 | 14 | 5 | 10 | 11 | 15 | 13 | 17 | 18 | 20 | 15 | 17 | 5 | 5 | 17 |
| Operating Profit % | 15 % | 18 % | 21 % | 25 % | 21 % | 12 % | 9 % | 6 % | 32 % | 30 % | 31 % | 29 % | 31 % | 22 % | 15 % | 13 % | 3 % | 14 % | 14 % | 19 % | 14 % | 17 % | 16 % | 16 % | 10 % | 12 % | 6 % | 7 % | 11 % |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 3 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 7 | 6 | 10 | 7 | 3 | 2 | 0 | 13 | 21 | 23 | 21 | 26 | 19 | 14 | 9 | 1 | 6 | 9 | 12 | 10 | 14 | 14 | 16 | 12 | 13 | 1 | 1 | 12 |
| Tax | 0 | 2 | 2 | 3 | 2 | 0 | 1 | 1 | 4 | 5 | 6 | 7 | 6 | 5 | 4 | 2 | 0 | 2 | 3 | 3 | 2 | 4 | 4 | 4 | 3 | 4 | 0 | 1 | 3 |
| Net Profit | 5 | 4 | 4 | 7 | 5 | 2 | 1 | -0 | 9 | 16 | 18 | 14 | 19 | 14 | 10 | 7 | 1 | 5 | 7 | 9 | 9 | 11 | 10 | 12 | 9 | 10 | 1 | 1 | 9 |
| EPS in ₹ | 8.04 | 7.15 | 6.59 | 11.02 | 8.41 | 3.80 | 1.82 | -0.32 | 15.19 | 25.59 | 28.67 | 22.40 | 30.96 | 22.52 | 16.10 | 11.12 | 0.84 | 7.56 | 10.50 | 15.09 | 13.77 | 16.96 | 16.24 | 19.95 | 14.92 | 15.88 | 2.07 | 0.88 | 14.96 |
NGL Fine Chem
NGL Fine Chem
1,388.50
-25.70
(-1.82%)
Market Cap
857.80 Cr
EPS
34.19
PE Ratio
41.21
Dividend Yield
0.13 %
Industry
Healthcare52 Week High
2,178.90
52 Week Low
957.00
PB Ratio
3.05
Debt to Equity
0.20
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
NGL Fine-Chem Limited invested approximately Rs. 119.83 crore in the first quarter of FY 2025-26 for expansion work at their S-18 plant. The company stated this investment is aimed at catering to future growth. This follows their earlier communication dated March 25, 2025 regarding the expansion plans.
NGL Fine-Chem Limited delivered topline growth in Q1FY26, primarily driven by higher volumes despite challenging industry conditions. Revenue from operations increased 9.70% quarter-on-quarter to ₹104.19 crores. EBITDA surged 73.64% to ₹10.97 crores with margins improving to 10.53% from 6.65% in the previous quarter. Profit after tax jumped significantly to ₹9.24 crores. The company's CAPEX project completion timeline has been extended by one quarter to Q4FY26 due to execution delays, with meaningful contributions expected from end of FY27. Management noted intensified competition from new capacity commissioning globally, putting pressure on product realizations, while currency volatility and geopolitical uncertainties affected input costs. The company maintains focus on diversification into regulated markets and continues progress on its ₹160 crore greenfield expansion at Tarapur, having invested ₹119.83 crores till Q1FY26. NGL Fine-Chem operates as a leading animal health company with 90% revenue from veterinary APIs, serving over 400 customers globally across three manufacturing facilities.
NGL Fine-Chem Limited's Board of Directors approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of ₹1,063.57 crores and standalone revenue of ₹1,074.15 crores for the quarter. Consolidated profit before tax stood at ₹1,183.95 crores while standalone profit before tax was ₹971.47 crores. The company's consolidated profit after tax was ₹924.06 crores compared to standalone profit of ₹764.41 crores. Basic earnings per share on consolidated basis was ₹29.91 and on standalone basis was ₹24.73. The company operates in pharmaceuticals manufacturing as a single business segment. The consolidated results include NGL Fine-Chem Limited and its wholly owned subsidiary Macrotech Polychem Private Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,586.70 | #1 3,80,702.50 | 33.18 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 51.86 | |
5,689.50 | 1,51,038.30 | 65.50 | 9,712.00 | 18.67 | 2,191 | 26.74 | 36.39 | |
1,499.40 | 1,21,107.70 | 22.45 | 28,409.50 | 7.12 | 5,291 | 9.88 | 38.89 | |
3,561.00 | 1,20,520.40 | 59.72 | 11,539.40 | 6.99 | 1,911 | 19.91 | 42.61 | |
1,253.10 | 1,04,580.10 | #1 18.40 | 33,741.20 | 16.73 | 5,725 | 1.26 | 46.51 | |
2,482.90 | 1,02,476.40 | 54.18 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 44.66 | |
975.00 | 98,107.80 | 21.07 | 23,511.00 | 18.55 | 4,615 | 2.60 | 50.50 | |
1,919.80 | 87,676.40 | 23.72 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.16 | |
5,433.00 | 64,959.70 | 28.53 | 13,458.30 | 3.70 | 2,216 | 21.39 | 61.31 | |
1,090.00 | 63,307.40 | 18.84 | 32,345.60 | 9.43 | 3,484 | -10.24 | 53.78 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
6.83 %
Net Income Growth
-48.91 %
Cash Flow Change
74.99 %
ROE
-52.45 %
ROCE
-53.88 %
EBITDA Margin (Avg.)
-40.94 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 142 | 154 | 207 | 277 | 287 | 356 | 433 |
| Fixed Assets | 61 | 68 | 64 | 89 | 88 | 86 | 143 |
| Current Assets | 79 | 81 | 125 | 174 | 163 | 213 | 235 |
| Capital Work in Progress | 0 | 0 | 12 | 6 | 26 | 46 | 50 |
| Investments | 9 | 11 | 29 | 29 | 40 | 54 | 60 |
| Other Assets | 73 | 75 | 102 | 153 | 133 | 171 | 181 |
| Total Liabilities | 142 | 154 | 207 | 277 | 287 | 356 | 433 |
| Current Liabilities | 38 | 43 | 42 | 66 | 58 | 87 | 119 |
| Non Current Liabilities | 12 | 12 | 11 | 8 | 6 | 6 | 32 |
| Total Equity | 92 | 99 | 155 | 203 | 223 | 263 | 282 |
| Reserve & Surplus | 89 | 96 | 151 | 200 | 220 | 260 | 279 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Cash Flow
| Cash Flow | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | -0 | 2 | -2 | 7 | -7 | 0 |
| Investing Activities | -10 | -20 | -25 | -14 | -27 | -27 | -35 |
| Operating Activities | 9 | 21 | 27 | 14 | 35 | 21 | 36 |
| Financing Activities | 0 | -1 | -1 | -1 | -1 | -1 | -1 |
Share Holding
| % Holding | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | May 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 74.49 % | 74.49 % | 74.49 % | 74.49 % | 74.49 % | 73.85 % | 73.85 % | 73.85 % | 73.85 % | 73.85 % | 73.85 % | 73.85 % | 73.85 % | 73.85 % | 73.83 % | 73.81 % | 73.81 % | 73.81 % | 73.81 % | 73.81 % | 73.81 % | 73.81 % | 73.81 % | 73.81 % | 73.53 % | 73.53 % | 73.06 % | 73.06 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % | 72.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.10 % | 0.03 % | 0.02 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.54 % | 19.66 % | 19.54 % | 20.37 % | 20.59 % | 21.24 % | 22.19 % | 21.23 % | 21.36 % | 21.55 % | 22.47 % | 21.28 % | 21.64 % | 21.71 % | 21.98 % | 21.97 % | 22.10 % | 22.28 % | 22.51 % | 22.28 % | 22.22 % | 22.19 % | 22.01 % | 21.78 % | 21.95 % | 21.81 % | 22.30 % | 21.89 % | 21.85 % | 21.81 % | 21.69 % | 21.70 % | 22.75 % | 23.00 % |
| Others | 5.97 % | 5.85 % | 5.97 % | 5.14 % | 4.91 % | 4.91 % | 3.97 % | 4.92 % | 4.79 % | 4.60 % | 3.68 % | 4.88 % | 4.51 % | 4.45 % | 4.19 % | 4.22 % | 4.09 % | 3.91 % | 3.68 % | 3.91 % | 3.97 % | 4.00 % | 4.18 % | 4.41 % | 4.52 % | 4.65 % | 4.64 % | 5.05 % | 5.31 % | 5.42 % | 5.56 % | 5.56 % | 4.51 % | 4.27 % |
| No of Share Holders | 3,574 | 3,620 | 3,574 | 3,800 | 3,972 | 4,194 | 4,310 | 4,373 | 4,235 | 4,413 | 4,239 | 4,440 | 4,609 | 4,508 | 4,453 | 5,456 | 7,146 | 10,832 | 15,695 | 17,068 | 17,807 | 18,042 | 18,504 | 18,440 | 18,287 | 17,066 | 17,623 | 16,410 | 15,041 | 14,608 | 14,575 | 14,110 | 14,386 | 14,010 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.75 | 1.75 | 0.00 | 1.75 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.08 | 0.00 | 0.13 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Aug 2021 |  Dividend | ₹ 1.75 /share | 12 Aug 2021 | 1,753.05 | 3,142.20 |
| 23 Jun 2022 | Dividend | ₹ 1.75 /share | 22 Jun 2022 | 2,167.40 | 1,647.40 |
| 18 Aug 2023 | Dividend | ₹ 1.75 /share | 18 Aug 2023 | 1,500.70 | 1,969.65 |
| 16 Aug 2024 | Dividend | ₹ 1.75 /share | 16 Aug 2024 | 2,332.25 | 2,325.85 |
| 23 Aug 2024 |  Annual General Meeting | NA | 23 Aug 2024 | 2,332.25 | 2,302.55 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 1,904.15 | 2,094.15 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 1,730.65 | 2,009.15 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 1,116.95 | 1,285.60 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 1,309.75 | 1,302.55 |
| 12 Aug 2025 | Dividend | ₹ 1.75 /share | 12 Aug 2025 | 1,285.60 | 1,217.20 |
| 19 Aug 2025 | Annual General Meeting | NA | 19 Aug 2025 | 1,285.60 | 1,366.20 |
Announcements
Closure of Trading Window
1 day ago
1 day agoShareholder Meeting / Postal Ballot-Scrutinizers ReportAug 19, 2025
Aug 19, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 19, 2025
Aug 19, 2025Regulation 30 UpdatesAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Aug 04, 2025Financial Results For Quarter Ended 30Th June 2025Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 01, 2025
Aug 01, 2025Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Jul 28, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 25, 2025
Jul 25, 2025Reg. 34 (1) Annual Report.Jul 25, 2025
Jul 25, 2025Shareholders Meeting As On 19Th August 2025Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Jul 24, 2025Board Meeting Intimation for Board Meeting IntimationJul 22, 2025
Jul 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 20, 2025
Jun 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2025
May 29, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Results For Quarter & Year Ended 31St March 2025May 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2025
May 23, 2025BOOK CLOSURE INTIMATIONMay 22, 2025
May 22, 2025RECORD DATEMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 22, 2025
May 22, 2025Corporate Action-Board approves DividendMay 22, 2025
May 22, 2025Financial Results For Quarter And Year Ended 31St March 2025May 22, 2025
May 22, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2025
May 14, 2025Board Meeting Intimation for Notice Of The First Board Meeting Of 2025-26 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 05, 2025
May 05, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 19, 2025
Apr 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Apr 03, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Intimation Pursuant To Reg. 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.Mar 25, 2025
Mar 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMar 25, 2025
Mar 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Mar 19, 2025Announcement under Regulation 30 (LODR)-Credit RatingMar 06, 2025
Mar 06, 2025UpdatesMar 06, 2025
Mar 06, 2025Announcement Under Reg.30Feb 25, 2025
Feb 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Feb 10, 2025Integrated Filing (Financial)Feb 07, 2025
Feb 07, 2025Technical Indicators
RSI(14)
Neutral 47.62
ATR(14)
Less Volatile 67.49
STOCH(9,6)
Neutral 61.59
STOCH RSI(14)
Neutral 38.79
MACD(12,26)
Bearish -7.96
ADX(14)
Weak Trend 22.62
UO(9)
Bearish 43.68
ROC(12)
Downtrend And Accelerating -0.76
WillR(14)
Neutral -62.71
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.02% | 0 | 0.00% | 0.01% |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
